Sickle cell patients are one of the largest utilizers of health care services. Sickle cell has the highest observed 30 day readmission rate for both inpatient hospital stays and emergency room encounters. In this paper, we discuss our experience developing and optimizing a care path and analytics platform for sickle cell anemia. This program focuses on key process and clinical measures designed to reduce cost and improve patient outcomes.
Describe the new knowledge and additional skills the participant will gain after attending your presentation.: The participant will learn the key measures used to address sickle cell anemia care and how to develop a program to drive performance improvement for these patients.
James McGlothlin (Presenter)
Fusion Consulting Inc
Ilija Stojic, Fusion Consulting Inc
Hari Srinivasan, Fusion Consulting Inc
Carissa Cianci, Loma Linda University Health System